San Diego-primarily based Viking Therapeutics marked by itself as a significant competitor from the weight loss drug market in February soon after revealing promising facts from the mid-phase trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when provided being a weekly injection As well as in Marc